Pipeline · Bill → Law
Step 1
Introduced
Jul 28, 2023
Step 2
Referred
Aug 4, 2023
E&C · Ways & Means
Step 3
Committee
Mar 6, 2024
Reported out
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill delays a change to the payment methodology under Medicare for oral drugs that are used to treat end-stage renal disease (ESRD). Under current regulations, beginning January 1, 2025, the Centers for Medicare & Medicaid Services will incorporate payments for oral-only ESRD drugs into the ESRD prospective payment system rather than issuing separate payments to ESRD facilities. The bill delays implementation of this policy until January 1, 2033, or until an approved intravenous drug is available, whichever is earlier.
Timeline · 12 actions
Jun 11, 2024
Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.
Mar 20, 2024
Committee Consideration and Mark-up Session Held
Mar 20, 2024
Ordered to be Reported (Amended) by the Yeas and Nays: 37 - 10.
Mar 12, 2024
Subcommittee Consideration and Mark-up Session Held
Mar 12, 2024
Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 16 - 10.
Mar 6, 2024
Committee Consideration and Mark-up Session Held
Mar 6, 2024
Committee Consideration and Mark-up Session Held
Mar 6, 2024
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 1.
Aug 4, 2023
Referred to the Subcommittee on Health.
Jul 28, 2023
Introduced in House
Jul 28, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 28, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.